Work

MA08.07 OCELOT: A Pan-Canadian Study of Osimertinib for Patients with Treatment Naive Advanced NSCLC with Uncommon EGFR Mutations

Year: 2025

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2025.09.163

Authors: D. Breadner, G. Liu, P. Wheatley-Price, I. Menjak, Y. Wang, J. Rothenstein, M. Valdes, P. Bains, R. Juergens, P. Cheema, M. Vincent

Institutions: Princess Margaret Cancer Centre, University of Ottawa, Ottawa Hospital Research Institute, Sunnybrook Health Science Centre, Odette Cancer Centre, BC Cancer Agency, Lakeridge Health, Grand River Hospital, Lions Gate Hospital, Juravinski Cancer Centre, William Osler Health System

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415519300

Cites:

Cited by:

Related to: 10